On January 26, 2026, Plus Automation, Inc., a Delaware corporation (“PlusAI”), announced that PlusAI and TRATON Group (“TRATON”) had entered into a non-binding letter of intent pursuant to which the parties agreed to accelerate certain research and development activities related to the development and scaled deployment of on-highway autonomous trucking solutions in the United States and Europe under a pre-existing agreement between the parties. It is anticipated that any definitive agreement related to the contemplated transaction will be executed following the closing of the business combination between PlusAI and Churchill Capital Corp IX (“Churchill IX”).
The non-binding letter of intent contemplates that, in consideration of the accelerated research and development activities, TRATON will pay $25,000,000 with payments to be made to PlusAI from time to time pursuant to an agreed upon work schedule and that the successor to Churchill IX following the business combination (the “Company”) will issue TRATON, or one of its affiliates, a warrant to purchase up to 5,000,000 shares of Class A Common Stock at an exercise price of $11.50 per share. The warrant will become exercisable as follows: the warrant will be exercisable for (1) 25% of the underlying shares upon recognition by the Company of $100 million in revenue from TRATON, (2) an additional 25% of the underlying the underlying shares upon recognition by the Company of an additional $100 million in revenue, and (3) the remaining 50% of the underlying shares upon recognition by the Company of an additional $200 million in revenue, such that the warrant will be fully exercisable upon recognition by the Company of an aggregate of $400 million in revenue. The warrants will expire on the seventh anniversary of the date of issue.
In addition, the non-binding letter of intent contemplates that TRATON will have the right to designate one individual to the board of directors of the Company, subject to customary qualifications. Such right will be exercisable for one time only and will not obligate the Company to renominate such individual in any future annual meeting or accept any replacement nominee if the initial TRATON designee later resigns or is otherwise unable to serve on the Company’s board of directors.
Additional Information About the Business Combination and Where to Find It
The business combination will be submitted to shareholders of Churchill IX for their consideration. Churchill IX has filed a Registration Statement with the SEC, which includes a proxy statement/prospectus that has been distributed to Churchill IX’s shareholders in connection with Churchill IX’s solicitation of proxies for the vote by Churchill IX’s shareholders in connection with the business combination and other matters described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to PlusAI stockholders in connection with the completion of the business combination. The Registration Statement has been declared effective by the SEC and Churchill IX has mailed a proxy statement/prospectus and other relevant documents to its shareholders as of the record date established for voting on the business combination. Before making any voting or investment decision, Churchill IX shareholders, PlusAI stockholders and other interested persons are advised to read the proxy statement/prospectus, as well as other documents filed with the SEC by Churchill IX in connection with the business combination, as these documents will contain important information about Churchill IX, PlusAI and the business combination. Shareholders may obtain a copy of the proxy statement statement/prospectus, as well as other documents filed by Churchill IX with the SEC, without charge, at the SEC’s website located at www.sec.gov or by directing a written request to Churchill Capital Corp IX, 640 Fifth Avenue, 12th Floor, New York, NY 10019.
Forward-Looking Statements
This Current Report on Form 8-K and the press release attached as an exhibit hereto include “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements may be identified by the use of words such as “plan,” “project,” “will,” “estimate,” “intend,” “expect,” “believe,” “target,” “continue,” “could,” “may,” “might,” “possible,” “potential,” “predict”, “accelerate” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. We have based these forward-looking statements on current expectations and projections about future events. These statements include: expectations regarding the completion of the business combination between PlusAI and Churchill IX; estimates of customer adoption rates and usage patterns; projections regarding the value and capabilities of autonomous driving solutions; projections of development and commercialization timelines; expectations regarding PlusAI’s ability to execute its business model; expectations regarding safety and system maturity of SuperDrive; PlusAI’s deployment of virtual driver software; PlusAI’s expectations concerning relationships with strategic partners, suppliers, governments, regulatory bodies and other third parties; future ventures or investments in companies, products, services, or technologies; the potential benefits of the business combination and expectations related to its terms and timing; and the potential for PlusAI to increase in value.
These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of PlusAI and Churchill IX.
These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such statements. Such risks and uncertainties include: that PlusAI is pursuing an emerging technology, faces significant technical challenges and may not achieve commercialization or market acceptance; PlusAI’s